Cargando…

Location of Triple-Negative Breast Cancers: Comparison with Estrogen Receptor-Positive Breast Cancers on MR Imaging

There has been a major need to better understand the biological characteristics of triple-negative breast cancers. Compared with estrogen receptor (ER)-positive cancers, several magnetic resonance (MR) imaging findings have been reported as characteristic findings. However, information regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Won Hwa, Han, Wonshik, Chang, Jung Min, Cho, Nariya, Park, In Ae, Moon, Woo Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301951/ https://www.ncbi.nlm.nih.gov/pubmed/25608004 http://dx.doi.org/10.1371/journal.pone.0116344

Ejemplares similares

Mutational Analysis of Triple-Negative Breast Cancer Using Targeted Kinome Sequencing
por: Yoo, Tae-Kyung, et al.
Publicado: (2022)

Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases
por: Lee, Sang Min, et al.
Publicado: (2015)

Estrogen Actions in Triple-Negative Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer
por: Yom, Cha Kyong, et al.
Publicado: (2013)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Correlation between High Resolution Dynamic MR Features and Prognostic Factors in Breast Cancer
por: Lee, Shin Ho, et al.
Publicado: (2008)

Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis
por: Shin, Hee-Chul, et al.
Publicado: (2016)

Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer
por: Hollmén, Maija, et al.
Publicado: (2015)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)

Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer
por: Yoen, Heera, et al.
Publicado: (2023)

The Role of PET/CT for Evaluating Breast Cancer
por: Yang, Sang Kyu, et al.
Publicado: (2007)

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012)

Features of Undiagnosed Breast Cancers at Screening Breast MR Imaging and Potential Utility of Computer-Aided Evaluation
por: Seo, Mirinae, et al.
Publicado: (2016)

Tumor growth rate of invasive breast cancers during wait times for surgery assessed by ultrasonography
por: Lee, Su Hyun, et al.
Publicado: (2016)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

Low Rates of Additional Cancer Detection by Magnetic Resonance Imaging in Newly Diagnosed Breast Cancer Patients Who Undergo Preoperative Mammography and Ultrasonography
por: Kim, Jisun, et al.
Publicado: (2014)

Intratumoral Heterogeneity of Breast Cancer Xenograft Models: Texture Analysis of Diffusion-Weighted MR Imaging
por: Yun, Bo La, et al.
Publicado: (2014)

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer
por: Bae, Soo Youn, et al.
Publicado: (2015)

Ductographic Findings of Breast Cancer
por: Cho, Nariya, et al.
Publicado: (2005)

Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012)

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
por: Keam, Bhumsuk, et al.
Publicado: (2007)

Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers
por: O’Meara, Tess, et al.
Publicado: (2020)

Imaging Surveillance for Survivors of Breast Cancer: Correlation between Cancer Characteristics and Method of Detection
por: Chu, A Jung, et al.
Publicado: (2017)

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer
por: Fan, Ying, et al.
Publicado: (2015)

Erratum: Imaging Surveillance for Survivors of Breast Cancer: Correlation between Cancer Characteristics and Method of Detection
por: Chu, A Jung, et al.
Publicado: (2017)

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Kim, Taeryung, et al.
Publicado: (2015)

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
por: Austin, David, et al.
Publicado: (2018)

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
por: Takano, Elena A., et al.
Publicado: (2023)

Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
por: Lee, Reeree, et al.
Publicado: (2022)

The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo
por: Saleh, Lubaid, et al.
Publicado: (2023)

Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer
por: Choi, Moon Jung, et al.
Publicado: (2023)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
por: Brumec, Maša, et al.
Publicado: (2021)

Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Role of Estrogen Receptor-Positive/Negative Ratios in Regulating Breast Cancer
por: Li, Yanchu, et al.
Publicado: (2022)

Clinical significance of morphologic characteristics in triple negative breast cancer
por: Ryu, Dong Won, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r23bab3q4fivtiqij46im24kvg